Structure Therapeutics
GPCR
GPCR
163 hedge funds and large institutions have $1.65B invested in Structure Therapeutics in 2024 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 65 increasing their positions, 49 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.49% less ownership
Funds ownership: 35.81% → 35.31% (-0.49%)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
39% less capital invested
Capital invested by funds: $2.69B → $1.65B (-$1.04B)
Holders
163
Holding in Top 10
5
Calls
$28.1M
Puts
$17.3M
Top Buyers
| 1 | +$42.8M | |
| 2 | +$15.6M | |
| 3 | +$12.2M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$8.75M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$8.14M |
Top Sellers
| 1 | -$52.6M | |
| 2 | -$31.4M | |
| 3 | -$20.7M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$18.9M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$18.7M |